Evaluation of L-carnitine in an animal model of cholesterol- induced atherosclerosis

Bahrami Bukani, M and Farhad, N and Mehrshad, A and Rostami, H and Abbasi, A and Zarei, L (2019) Evaluation of L-carnitine in an animal model of cholesterol- induced atherosclerosis. Tropical Journal of Pharmaceutical Research, 18 (8). pp. 1661-1666.

Preview

Text 1751.pdf Download (187kB) | Preview

Abstract

To explore the effect of L-carnitine on atherosclerotic plaques in hyperlipidemic rabbits. Methods: Twenty five male white New Zealand rabbits were randomized into five groups (n = 5): In the normal control (NC) group, the animals were fed on a plain chow diet for 75 days. In atherosclerosis (AS) group, the animals were fed on a hypercholesterolemic diet for 75 days. In atorvastatin (ATOR) group, the animals were fed on a hypercholesterolemic diet for 75 days and received atorvastatin via oral gavage (20 mg/kg/day) from day 45 for 30 days. In L-carnitine (L) group, the animals were fed on a hypercholesterolemic diet for 75 days and received intraperitoneal L-carnitine (250 mg/kg/day) from day 45 for 30 days (end of the study). In ATOR/L group, the animals were fed on a hypercholesterolemic diet for 75 days, and received both atorvastatin and L-carnitine with the aforementioned dosage from day 45 for 30 days. Triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low- density lipoprotein (LDL-C) in sera were determined. The aorta, including the ascending and descending parts, was excised to measure plague size (end of the study). The blood samples were taken from a marginal ear vein. Results: Rabbits in AS group showed highly significant increase in serum total cholesterol and LDL-C levels compared to NC group (p < 0.05). Daily administration of L-carnitine significantly reduced serum levels of total cholesterol and LDL-C compared to AS (positive control) group (p < 0.05). Additionally, no significant difference was found between serum levels of total cholesterol and LDL-C in groups that received either atorvastatin or L-carnitine (p > 0.05). Combined administration of L-carnitine and atorvastatin produced no benefits over either of them alone (p > 0.05). Conclusion: The results indicate that the administration of L-carnitine has anti-atherosclerotic effects by reducing oxidized LDL cholesterol levels but further investigations are recommended to ascertain these findings.

Actions (login required)

View Item